Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin
- 1 January 1986
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 30 (1) , 69-73
- https://doi.org/10.1007/bf00614198
Abstract
The effect of aspirin on the in vivo formation of prostacyclin and thromboxane A2 in normal healthy individuals was studied by measuring the urinary excretion of 2,3-dinor-6-keto-PGF1α and 2,3-dinor-TxB2 by gas chromatography-mass spectrometry. Administration of 500 mg aspirin twice daily caused a sustained reduction in the excretion of 2,3-dinor-TxB2 to 10–15% of the predose value, while the excretion of 2,3-dinor-6-keto-PGF1α was reduced for only about 3 hours after the aspirin dose. The data demonstrate a considerable difference in the inhibitory effect of aspirin on the in vivo synthesis of thromboxane A2 and prostacyclin.Keywords
This publication has 16 references indexed in Scilit:
- Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1∝ and determination of the urinary excretion rates in healthy humans under normal conditions and following drugsProstaglandins, 1984
- Urinary excretion of 2,3-dinor-thromboxane B2 in man under normal conditions, following drugs and during some pathological conditionsProstaglandins, 1984
- Analysis of prostacyclinProstaglandins, 1984
- Regulation of urinary thromboxane B2 in man: Influence of urinary flow rate and tubular transportProstaglandins, 1984
- Development of a GC-MS method for quantitation of 2, 3-dinor-TXB2 and determinations of the daily urinary excretion rates in healthy humansThrombosis Research, 1984
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- Chapter 2 The thromboxanesNew Comprehensive Biochemistry, 1983
- The chemical structure of prostaglandin X (prostacyclin)Prostaglandins, 1976
- The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.Journal of Clinical Investigation, 1975
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975